These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 11244498

  • 1. Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells.
    Balañá ME, Labriola L, Salatino M, Movsichoff F, Peters G, Charreau EH, Elizalde PV.
    Oncogene; 2001 Jan 04; 20(1):34-47. PubMed ID: 11244498
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
    Salatino M, Schillaci R, Proietti CJ, Carnevale R, Frahm I, Molinolo AA, Iribarren A, Charreau EH, Elizalde PV.
    Oncogene; 2004 Jul 01; 23(30):5161-74. PubMed ID: 15122317
    [Abstract] [Full Text] [Related]

  • 3. Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas.
    Balañá ME, Lupu R, Labriola L, Charreau EH, Elizalde PV.
    Oncogene; 1999 Nov 04; 18(46):6370-9. PubMed ID: 10597237
    [Abstract] [Full Text] [Related]

  • 4. Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells.
    Labriola L, Salatino M, Proietti CJ, Pecci A, Coso OA, Kornblihtt AR, Charreau EH, Elizalde PV.
    Mol Cell Biol; 2003 Feb 04; 23(3):1095-111. PubMed ID: 12529413
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Type I insulin-like growth factor receptor antisense strategies in experimental breast cancer].
    Salatino M, Schillaci R, Proietti CJ, Carnevale R, Charreau EH, Elizalde PV.
    Medicina (B Aires); 2004 Feb 04; 64(2):129-34. PubMed ID: 15628299
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation.
    Salatino M, Beguelin W, Peters MG, Carnevale R, Proietti CJ, Galigniana MD, Vedoy CG, Schillaci R, Charreau EH, Sogayar MC, Elizalde PV.
    Oncogene; 2006 Dec 14; 25(59):7723-39. PubMed ID: 16799639
    [Abstract] [Full Text] [Related]

  • 10. Regulation of cell growth of a progestin-dependent murine mammary carcinoma in vitro: progesterone receptor involvement in serum or growth factor-induced cell proliferation.
    Lamb C, Simian M, Molinolo A, Pazos P, Lanari C.
    J Steroid Biochem Mol Biol; 1999 Dec 14; 70(4-6):133-42. PubMed ID: 10622401
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors.
    Salatino M, Labriola L, Schillaci R, Charreau EH, Elizalde PV.
    Exp Cell Res; 2001 Apr 15; 265(1):152-66. PubMed ID: 11281653
    [Abstract] [Full Text] [Related]

  • 12. Immunization with murine breast cancer cells treated with antisense oligodeoxynucleotides to type I insulin-like growth factor receptor induced an antitumoral effect mediated by a CD8+ response involving Fas/Fas ligand cytotoxic pathway.
    Schillaci R, Salatino M, Cassataro J, Proietti CJ, Giambartolomei GH, Rivas MA, Carnevale RP, Charreau EH, Elizalde PV.
    J Immunol; 2006 Mar 15; 176(6):3426-37. PubMed ID: 16517711
    [Abstract] [Full Text] [Related]

  • 13. [Growth hormones and oncogenes in mammary adenocarcinomas induced by medroxyprogesterone acetate in BALB/c mice].
    Elizalde PV, Balaña ME, Charreau EH.
    Medicina (B Aires); 1997 Mar 15; 57 Suppl 2():70-4. PubMed ID: 9580484
    [Abstract] [Full Text] [Related]

  • 14. Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor.
    Knowlden JM, Hutcheson IR, Barrow D, Gee JM, Nicholson RI.
    Endocrinology; 2005 Nov 15; 146(11):4609-18. PubMed ID: 16037379
    [Abstract] [Full Text] [Related]

  • 15. Recombinant human insulin-like growth factor binding protein 3 inhibits growth of human epidermal growth factor receptor-2-overexpressing breast tumors and potentiates herceptin activity in vivo.
    Jerome L, Alami N, Belanger S, Page V, Yu Q, Paterson J, Shiry L, Pegram M, Leyland-Jones B.
    Cancer Res; 2006 Jul 15; 66(14):7245-52. PubMed ID: 16849573
    [Abstract] [Full Text] [Related]

  • 16. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.
    Ram TG, Dilts CA, Dziubinski ML, Pierce LJ, Ethier SP.
    Mol Carcinog; 1996 Mar 15; 15(3):227-38. PubMed ID: 8597535
    [Abstract] [Full Text] [Related]

  • 17. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins.
    Lanari C, Lüthy I, Lamb CA, Fabris V, Pagano E, Helguero LA, Sanjuan N, Merani S, Molinolo AA.
    Cancer Res; 2001 Jan 01; 61(1):293-302. PubMed ID: 11196177
    [Abstract] [Full Text] [Related]

  • 18. Insulin-like growth factor-1 receptor and ErbB kinase inhibitor combinations block proliferation and induce apoptosis through cyclin D1 reduction and Bax activation.
    Wilsbacher JL, Zhang Q, Tucker LA, Hubbard RD, Sheppard GS, Bamaung NY, Fidanze SD, Wang GT, Hu X, Davidsen SK, Bell RL, Wang J.
    J Biol Chem; 2008 Aug 29; 283(35):23721-30. PubMed ID: 18559346
    [Abstract] [Full Text] [Related]

  • 19. Benzo[a]pyrene- and TCDD-induced alterations in tyrosine phosphorylation and insulin-like growth factor signaling pathways in the MCF-10A human mammary epithelial cell line.
    Tannheimer SL, Ethier SP, Caldwell KK, Burchiel SW.
    Carcinogenesis; 1998 Jul 29; 19(7):1291-7. PubMed ID: 9683191
    [Abstract] [Full Text] [Related]

  • 20. Small interfering RNA targeted to IGF-IR delays tumor growth and induces proinflammatory cytokines in a mouse breast cancer model.
    Durfort T, Tkach M, Meschaninova MI, Rivas MA, Elizalde PV, Venyaminova AG, Schillaci R, François JC.
    PLoS One; 2012 Jul 29; 7(1):e29213. PubMed ID: 22235273
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.